Why Monj shows pay-later information
Monj is adding pay-later as an optional filter near the bottom of the filter area. This is not a recommendation to use credit, and it does not change how providers are ranked. It is there because some users told us they want clearer checkout information before leaving Monj to visit a provider.
What users said
The result leaned towards showing the information, but it was not one-sided. That is why Monj is treating this as a small clarity filter, not as a selling point.
The patient-first reason
Some people want to know what may happen at checkout before they click through. Others are rightly cautious about pay-later being shown near prescription medicine. Monj’s answer is to show it carefully, lower down in the filters, with clear wording.
Monj’s position
We will show pay-later information only as a practical checkout clue. It will not affect ranking, it will not be treated as a provider benefit, and it will not be used to encourage anyone to choose treatment they cannot comfortably afford.
How this will appear in the filters
Price, provider checks, pharmacy registration and clinical suitability matter more. Pay-later is secondary checkout information, so it belongs lower in the filter list.
Providers will not move up because they offer it. Monj will continue to keep ranking separate from payment options.
Pay-later can change when money leaves your account, but it does not make treatment cheaper. The final total and affordability still matter.
Some users prefer to know checkout options before clicking away from Monj. This filter gives practical information without pushing a payment choice.
A provider still needs to assess whether treatment is suitable. A payment option should never be the reason someone chooses prescription medicine.
The poll showed mixed views, so Monj is taking a balanced route: show the information for those who want it, but keep it factual, restrained and clearly explained.
In plain English
Monj is not promoting pay-later. We are adding a small optional filter so users can understand more about checkout before visiting a provider. The filter is there for clarity only. It does not affect rankings, it does not make a provider better, and it should never replace checking the full price, affordability, prescription assessment and provider suitability.
Poll export reviewed: 378 entries, with 365 clean valid votes counted in the public breakdown. The export shows voter details are used for moderation only, with IP and user-agent stored as one-way hashes and device/browser information shown only as broad, non-identifying signals.
Sources referenced on this page
Standing primary references for every Monj page:
- Mounjaro (tirzepatide) Summary of Product Characteristics and Patient Information Leaflet, electronic medicines compendium
- MHRA Drug Safety Update: GLP-1 receptor agonists
- NICE TA1026: tirzepatide for managing overweight and obesity
- General Pharmaceutical Council register of pharmacies
- MHRA Yellow Card scheme
